ACM
IMUX icon

ADAR1 Capital Management’s Immunic IMUX Stock Holding History

ADAR1 Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed – – 308
2026
Q1 		$0 Buy
+3,000
New +$26.9K ﹤0.01% 324

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ADAR1 Capital Management's IMUX Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Immunic (IMUX) in Q2 2026, closing a stake of 3,000 shares.

ADAR1 Capital Management first reported a position in IMUX in Q1 2026 and held it in 1 quarter. The position peaked at $0 in Q1 2026. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 3,000 Immunic shares in Q2 2026.
  • ADAR1 Capital Management first reported a position in Immunic in Q1 2026 and held it in 1 quarter.
  • ADAR1 Capital Management's Immunic position peaked at $0 in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.